Antimicrobial Therapy for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria / 대한내과학회지
Korean Journal of Medicine
;
: 439-446, 2018.
Artigo
em Coreano
| WPRIM
| ID: wpr-717699
ABSTRACT
Carbapenem-resistance emerging in Gram-negative pathogens, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, has become a major human health problem globally. The therapeutic options available for carbapenem-resistant pathogens are very limited. Antibiotics such as colistin, tigecycline, fosfomycin, and aminoglycosides are often the only ones that can be used to treat carbapenem-resistant pathogens. Carbapenem may still be an option in certain circumstances. The administration of combination therapy for carbapenem-resistant pathogens is controversial. This review presents the current knowledge of available antimicrobial therapeutic options for infections due to carbapenem-resistant pathogens in Korea.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pseudomonas aeruginosa
/
Resistência a Medicamentos
/
Resultado do Tratamento
/
Colistina
/
Acinetobacter baumannii
/
Fosfomicina
/
Bactérias Gram-Negativas
/
Aminoglicosídeos
/
Klebsiella pneumoniae
/
Coreia (Geográfico)
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS